T. Rowe Price Associates’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Sell |
504,828
-14,957
| -3% | -$93.7K | ﹤0.01% | 1451 |
|
|
2025
Q1 | $3.05M | Sell |
519,785
-37,156
| -7% | -$218K | ﹤0.01% | 1421 |
|
|
2024
Q4 | $4.58M | Buy |
556,941
+40,815
| +8% | +$336K | ﹤0.01% | 1307 |
|
|
2024
Q3 | $4.6M | Sell |
516,126
-57,514
| -10% | -$513K | ﹤0.01% | 1320 |
|
|
2024
Q2 | $4.34M | Sell |
573,640
-21,900
| -4% | -$166K | ﹤0.01% | 1263 |
|
|
2024
Q1 | $4.68M | Sell |
595,540
-64,152
| -10% | -$504K | ﹤0.01% | 1231 |
|
|
2023
Q4 | $5.85M | Buy |
659,692
+2,663
| +0.4% | +$23.6K | ﹤0.01% | 1175 |
|
|
2023
Q3 | $5.9M | Sell |
657,029
-8,499
| -1% | -$76.3K | ﹤0.01% | 1146 |
|
|
2023
Q2 | $8.22M | Sell |
665,528
-45,077
| -6% | -$557K | ﹤0.01% | 1100 |
|
|
2023
Q1 | $6.6M | Sell |
710,605
-28,610
| -4% | -$266K | ﹤0.01% | 1123 |
|
|
2022
Q4 | $7.76M | Buy |
+739,215
| New | +$7.76M | ﹤0.01% | 1095 |
|